Fig. 8: Graph abstracts.

P2Y₁₄R activation is involved in the pathogenesis of IBD by regulating necroptosis of IECs via PKA/CREB/RIPK1 axis. P2Y₁₄R-targeted intervention by a potent antagonist HDL-16 exhibits notable therapeutic effects on DSS-induced colitis in mice.